{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:41:48Z","timestamp":1789170108230,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s13555-025-01577-x","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:44:30Z","timestamp":1762346670000},"page":"365-376","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["HDR Mould-Based Brachytherapy for Cutaneous Neoplasms: Toxicity, Long-Term Control, Cosmesis and PROMs"],"prefix":"10.1007","volume":"16","author":[{"given":"Markus","family":"Diefenhardt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7800-6127","authenticated-orcid":false,"given":"Nikolaos","family":"Tselis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Achenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Kleemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Zeiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastian","family":"Schilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Scherf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Chatzikonstantinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla","family":"Ramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"R\u00f6del","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Licher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"1577_CR1","unstructured":"WHO IAfRoC. Skin cancer; 2024. https:\/\/www.iarc.who.int\/cancer-type\/skin-cancer\/#:~:text=Skin%20cancers%20are%20the%20most,people%20died%20from%20the%20disease."},{"key":"1577_CR2","unstructured":"Network NCC. NCCN Clinical Practice Guidelines in Oncology Squamous Cell Skin Cancer\u2014V 1.2024; 2024. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/squamous.pdf."},{"key":"1577_CR3","unstructured":"Networt NCC. NCCN Clinical Practice Guidelines in Oncology\u2014Basal cell skin cancer V 3.2024; 2024. [updated 2024\/09\/03]. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/nmsc.pdf."},{"issue":"3","key":"1577_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.5114\/jcb.2016.61066","volume":"8","author":"L Kuncman","year":"2016","unstructured":"Kuncman L, Kozlowski S, Pietraszek A, Pietrzykowska-Kuncman M, Danielska J, Sobotkowski J, et\u00a0al. Highly conformal CT based surface mould brachytherapy for non-melanoma skin cancers of earlobe and nose. J Contemp Brachytherapy. 2016;8(3):195\u2013200.","journal-title":"J Contemp Brachytherapy"},{"issue":"2","key":"1577_CR5","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.brachy.2018.11.001","volume":"18","author":"S-Y Park","year":"2019","unstructured":"Park S-Y, Kang S, Park JM, An HJ, Oh DH, Kim J-i. Development and dosimetric assessment of a patient-specific elastic skin applicator for high-dose-rate brachytherapy. Brachytherapy. 2019;18(2):224\u201332.","journal-title":"Brachytherapy"},{"issue":"2","key":"1577_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.5114\/jcb.2021.105286","volume":"13","author":"C Scherf","year":"2021","unstructured":"Scherf C, Licher J, Mletzko C, Trommel M, Tselis N, Chatzikonstantinou G, et\u00a0al. Individualized mould-based high-dose-rate brachytherapy for perinasal skin tumors: technique evaluation from a dosimetric point of view. J Contemp Brachytherapy. 2021;13(2):179\u201387.","journal-title":"J Contemp Brachytherapy"},{"issue":"6","key":"1577_CR7","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/ijd.15492","volume":"60","author":"M Diefenhardt","year":"2021","unstructured":"Diefenhardt M, Chatzikonstantinou G, Meissner M, Kohn J, Scherf C, Trommel M, et\u00a0al. HDR brachytherapy with individual epithetic molds for facial skin cancer: techniques and first clinical experience. Int J Dermatol. 2021;60(6):717\u201323.","journal-title":"Int J Dermatol"},{"issue":"1","key":"1577_CR8","first-page":"35","volume":"21","author":"G Chatzikonstantinou","year":"2023","unstructured":"Chatzikonstantinou G, Diefenhardt M, Fleischmann M, Meissner M, Scherf C, Trommel M, et\u00a0al. Customized 3d-printed molds for high dose-rate brachytherapy in facial skin cancer: first clinical experience. JDDG J Dtsch Dermatol Ges. 2023;21(1):35\u201341.","journal-title":"JDDG J Dtsch Dermatol Ges"},{"issue":"1","key":"1577_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s13246-021-01092-1","volume":"45","author":"CA Bridger","year":"2022","unstructured":"Bridger CA, Reich PD, Caraca Santos AM, Douglass MJJ. A dosimetric comparison of CT- and photogrammetry-generated 3D printed HDR brachytherapy surface applicators. Phys Eng Sci Med. 2022;45(1):125\u201334.","journal-title":"Phys Eng Sci Med"},{"issue":"2","key":"1577_CR10","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.brachy.2022.10.011","volume":"22","author":"R Bienvenido","year":"2023","unstructured":"Bienvenido R, Quinones LA, Perez J, Castro I, Gutierrez L, Lopez JD, et\u00a0al. Study of dose dependence on density in planar 3D-printed applicators for HDR Ir(192) surface brachytherapy. Brachytherapy. 2023;22(2):250\u20139.","journal-title":"Brachytherapy"},{"issue":"6","key":"1577_CR11","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.brachy.2021.05.164","volume":"20","author":"I MembriveConejo","year":"2021","unstructured":"MembriveConejo I, PeraCegarra O, ForoArnalot P, ReigCastillejo A, Rodriguez de Dios N, Sanz Latiesas X, et\u00a0al. Custom 3D-printed applicators for high dose-rate brachytherapy in skin cancer. Brachytherapy. 2021;20(6):1257\u201364.","journal-title":"Brachytherapy"},{"issue":"3","key":"1577_CR12","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/mp.13975","volume":"47","author":"CV Guthier","year":"2020","unstructured":"Guthier CV, Devlin PM, Harris TC, O\u2019Farrell DA, Cormack RA, Buzurovic I. Development and clinical implementation of semi-automated treatment planning including 3D printable applicator holders in complex skin brachytherapy. Med Phys. 2020;47(3):869\u201379.","journal-title":"Med Phys"},{"issue":"3","key":"1577_CR13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.radonc.2018.01.013","volume":"126","author":"JL Guinot","year":"2018","unstructured":"Guinot JL, Rembielak A, Perez-Calatayud J, Rodriguez-Villalba S, Skowronek J, Tagliaferri L, et\u00a0al. GEC-ESTRO ACROP recommendations in skin brachytherapy. Radiother Oncol. 2018;126(3):377\u201385.","journal-title":"Radiother Oncol"},{"issue":"11","key":"1577_CR14","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1007\/s00330-008-1015-9","volume":"18","author":"JH Kim","year":"2008","unstructured":"Kim JH, Kim JY, Chun KA, Jee WH, Sung MS. MR imaging manifestations of skin tumors. Eur Radiol. 2008;18(11):2652\u201361.","journal-title":"Eur Radiol"},{"issue":"2","key":"1577_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2020.10.028","volume":"6","author":"JM Taylor","year":"2021","unstructured":"Taylor JM, Dasgeb B, Liem S, Ali A, Harrison A, Finkelstein M, et\u00a0al. High-dose-rate brachytherapy for the treatment of basal and squamous cell carcinomas on sensitive areas of the face: a report of clinical outcomes and acute and subacute toxicities. Adv Radiat Oncol. 2021;6(2):100616.","journal-title":"Adv Radiat Oncol"},{"issue":"3","key":"1577_CR16","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.brachy.2021.01.009","volume":"20","author":"S Renard","year":"2021","unstructured":"Renard S, Salleron J, Py JF, Cuenin M, Buchheit I, Marchesi V, et\u00a0al. High-dose-rate brachytherapy for facial skin cancer: outcome and toxicity assessment for 71 cases. Brachytherapy. 2021;20(3):624\u201330.","journal-title":"Brachytherapy"},{"issue":"2","key":"1577_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.5114\/jcb.2018.75596","volume":"10","author":"B Kalaghchi","year":"2018","unstructured":"Kalaghchi B, Esmati E, Ghalehtaki R, Gomar M, Jaberi R, Gholami S, et\u00a0al. High-dose-rate brachytherapy in treatment of non-melanoma skin cancer of head and neck region: preliminary results of a prospective single institution study. J Contemp Brachytherapy. 2018;10(2):115\u201322.","journal-title":"J Contemp Brachytherapy"},{"issue":"6","key":"1577_CR18","doi-asserted-by":"publisher","first-page":"533","DOI":"10.5114\/jcb.2016.64112","volume":"8","author":"D Delishaj","year":"2016","unstructured":"Delishaj D, Rembielak A, Manfredi B, Ursino S, Pasqualetti F, Laliscia C, et\u00a0al. Non-melanoma skin cancer treated with high-dose-rate brachytherapy: a review of literature. J Contemp Brachytherapy. 2016;8(6):533\u201340.","journal-title":"J Contemp Brachytherapy"},{"issue":"3","key":"1577_CR19","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.jgo.2018.09.009","volume":"10","author":"V Lancellotta","year":"2019","unstructured":"Lancellotta V, Kovacs G, Tagliaferri L, Perrucci E, Rembielak A, Stingeni L, et\u00a0al. The role of personalized interventional radiotherapy (brachytherapy) in the management of older patients with non-melanoma skin cancer. J Geriatr Oncol. 2019;10(3):514\u20137.","journal-title":"J Geriatr Oncol"},{"issue":"1","key":"1577_CR20","doi-asserted-by":"publisher","first-page":"S118","DOI":"10.1016\/j.ijrobp.2014.05.549","volume":"90","author":"S Vyas","year":"2014","unstructured":"Vyas S, Palaniswaamy G, Massingill B, Thawani N, Mutyala S. Electrons versus surface brachytherapy for non-melanoma skin cancer- a matched pair analysis. Int J Radiat Oncol Biol Phys. 2014;90(1):S118.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1577_CR21","unstructured":"Aging NIo. Talking with your older patients; 2023. https:\/\/www.nia.nih.gov\/health\/health-care-professionals-information\/talking-your-older-patients#:~:text=Avoid%20hurrying%20older%20patients.&text=Some%20people%20may%20have%20trouble,reveal%20all%20of%20their%20concerns."},{"issue":"3","key":"1577_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002530","volume":"15","author":"T Hoffmann","year":"2018","unstructured":"Hoffmann T, Jansen J, Glasziou P. The importance and challenges of shared decision making in older people with multimorbidity. PLoS Med. 2018;15(3):e1002530.","journal-title":"PLoS Med"},{"issue":"7","key":"1577_CR23","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.jgo.2021.04.006","volume":"12","author":"A Jochems","year":"2021","unstructured":"Jochems A, Bastiaannet E, Aarts MJB, van Akkooi ACJ, van den Berkmortel F, Boers-Sonderen MJ, et\u00a0al. Outcomes for systemic therapy in older patients with metastatic melanoma: results from the Dutch Melanoma Treatment Registry. J Geriatr Oncol. 2021;12(7):1031\u20138.","journal-title":"J Geriatr Oncol"},{"issue":"1","key":"1577_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.5114\/jcb.2021.103587","volume":"13","author":"E Gogineni","year":"2021","unstructured":"Gogineni E, Cai H, Carillo D, Rana Z, Bloom B, Potters L, et\u00a0al. Computed tomography-based flap brachytherapy for non-melanoma skin cancers of the face. J Contemp Brachytherapy. 2021;13(1):51\u20138.","journal-title":"J Contemp Brachytherapy"},{"issue":"4","key":"1577_CR25","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.brachy.2021.01.007","volume":"20","author":"J Roberson","year":"2021","unstructured":"Roberson J, Patel R, Slutsky JB, Ryu S, Xu Z, Valentine E. Tumor control and cosmetic outcome of weekly iridium-192 high-dose-rate brachytherapy for nonmelanoma skin cancers in the elderly. Brachytherapy. 2021;20(4):818\u201327.","journal-title":"Brachytherapy"},{"issue":"1","key":"1577_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.5114\/wo.2021.104688","volume":"25","author":"C Laliscia","year":"2021","unstructured":"Laliscia C, Fuentes T, Coccia N, Mattioni R, Perrone F, Paiar F. High-dose-rate brachytherapy for non-melanoma skin cancer using tailored custom moulds - A single-centre experience. Wspolczesna Onkol. 2021;25(1):12\u20136.","journal-title":"Wspolczesna Onkol"},{"issue":"5","key":"1577_CR27","doi-asserted-by":"publisher","first-page":"435","DOI":"10.5114\/jcb.2020.100376","volume":"12","author":"ACA Pellizzon","year":"2020","unstructured":"Pellizzon ACA, Fogaroli R, Chen MJ, Maia P, Gondim G, Guedes DC, et\u00a0al. High-dose-rate brachytherapy using Leipzig applicators for non-melanoma localized skin cancer. J Contemp Brachytherapy. 2020;12(5):435\u201340.","journal-title":"J Contemp Brachytherapy"},{"issue":"3","key":"1577_CR28","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.brachy.2018.01.002","volume":"17","author":"D Olek Jr","year":"2018","unstructured":"Olek D Jr, El-Ghamry MN, Deb N, Thawani N, Shaver C, Mutyala S. Custom mold applicator high-dose-rate brachytherapy for nonmelanoma skin cancer-an analysis of 273 lesions. Brachytherapy. 2018;17(3):601\u20138.","journal-title":"Brachytherapy"},{"issue":"20","key":"1577_CR29","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1002\/cncr.32371","volume":"125","author":"CT Lee","year":"2019","unstructured":"Lee CT, Lehrer EJ, Aphale A, Lango M, Galloway TJ, Zaorsky NG. Surgical excision, Mohs micrographic surgery, external-beam radiotherapy, or brachytherapy for indolent skin cancer: an international meta-analysis of 58 studies with 21,000 patients. Cancer. 2019;125(20):3582\u201394.","journal-title":"Cancer"},{"issue":"5","key":"1577_CR30","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.21873\/anticanres.14266","volume":"40","author":"SB Bateni","year":"2020","unstructured":"Bateni SB, Johns AJ, Gingrich AA, Gholami S, Bold RJ, Canter RJ, et\u00a0al. Elderly age is associated with more conservative treatment of invasive melanoma. Anticancer Res. 2020;40(5):2895\u2013903.","journal-title":"Anticancer Res"},{"key":"1577_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f6153","volume":"347","author":"L Lansbury","year":"2013","unstructured":"Lansbury L, Bath-Hextall F, Perkins W, Stanton W, Leonardi-Bee J. Interventions for non-metastatic squamous cell carcinoma of the skin: systematic review and pooled analysis of observational studies. BMJ. 2013;347:f6153.","journal-title":"BMJ"},{"key":"1577_CR32","unstructured":"Network NCC. NCCN Clinical Practice Guidelines in Oncology Melanoma: cutaneous V 2.2024; 2024. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cutaneous_melanoma.pdf."},{"issue":"16_suppl","key":"1577_CR33","doi-asserted-by":"publisher","first-page":"9502","DOI":"10.1200\/JCO.2024.42.16_suppl.9502","volume":"42","author":"AM Hong","year":"2024","unstructured":"Hong AM, Lo SN, Fogarty GB, Stretch J, Wang W, Penas PF, et\u00a0al. A randomised, controlled, multicentre trial of imiquimod versus radiotherapy for lentigo maligna. J Clin Oncol. 2024;42(16_suppl):9502.","journal-title":"J Clin Oncol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01577-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-025-01577-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01577-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T07:40:25Z","timestamp":1770190825000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-025-01577-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1577"],"URL":"https:\/\/doi.org\/10.1007\/s13555-025-01577-x","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"2 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Markus Diefenhardt, Nikolaos Tselis, Julia Achenbach, Johannes Kleemann, Kim Zeiner, Bastian Schilling, Christian Scherf, Georgios Chatzikonstantinou, Ulla Ramm, Claus R\u00f6del and J\u00f6rg Licher have no conflicts of interest to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study adhered to the Strengthening the Reporting of Observational Studies in Epidemiology reporting guidelines for cohort studies and the principles outlined in the Declaration of Helsinki. The submitted study was approved by the ethics board of the Goethe University Frankfurt (no. 2021-564). All patients provided written informed consent to participate in the study and for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}